1 / 2

BUD/FORM maintenance and reliever therapy; n=2173 Double-dose ICS/LABA + SABA; n=3246

Percentage of Patients with Well-controlled, Intermediate or Uncontrolled Asthma on Treatment. BUD/FORM maintenance and reliever therapy; n=2173 Double-dose ICS/LABA + SABA; n=3246. A) Well controlled: ACQ ≤0.75. B) Intermediate*: ACQ 0.76-1.49. C) Uncontrolled: ACQ ≥1.5. P =0.035.

henrik
Download Presentation

BUD/FORM maintenance and reliever therapy; n=2173 Double-dose ICS/LABA + SABA; n=3246

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Percentage of Patients with Well-controlled, Intermediate or Uncontrolled Asthma on Treatment BUD/FORM maintenance and reliever therapy; n=2173 Double-dose ICS/LABA + SABA; n=3246 A) Well controlled: ACQ ≤0.75 B) Intermediate*: ACQ 0.76-1.49 C) Uncontrolled: ACQ ≥1.5 P=0.035 Patients uncontrolled (%) Patients well controlled (%) Patients with intermediate control* (%) BUD/FORM = budesonide/formoterol *Patients in whom asthma control cannot be assured. Results include only patients with ACQ reported both at baseline and at least once during the treatment period. Adapted from ERS 2008.

More Related